Company Parnell Pharmaceuticals Holdings Ltd Other OTC
Equities
PARNF
AU0000XINEU9
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Production Animal - U.S.
41.2
%
| 7 | 48.0 % | 8 | 41.2 % | +16.22% |
Manufacturing
38.9
%
| 3 | 22.7 % | 8 | 38.9 % | +131.78% |
Companion Animal
11.9
%
| 3 | 17.1 % | 2 | 11.9 % | -5.90% |
Production Animal - Rest of World
7.9
%
| 2 | 12.2 % | 2 | 7.9 % | -12.18% |
Sales per region
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
United States
84.0
%
| 11 | 77.7 % | 17 | 84.0 % | +46.20% |
Australia
11.8
%
| 2 | 14.1 % | 2 | 11.8 % | +13.76% |
Other Countries
2.6
%
| 1 | 6.7 % | 1 | 2.6 % | -46.85% |
New Zealand
1.5
%
| 0 | 1.6 % | 0 | 1.5 % | +32.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 31/01/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 20/12/20 |
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 31/01/10 |
Chairman | 67 | 31/12/05 | |
John Benear
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,023,814 | 18,023,814 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Parnell Pharmaceuticals Holdings Ltd.
Unit 4 Century Estate 476 Gardeners Road
2015, Sydney
+61 2 9667 4411
http://www.parnell.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-14.44% | 77.05B | |
+14.56% | 8.44B | |
+25.88% | 3.73B | |
+18.24% | 1.69B | |
-8.82% | 1.52B | |
-22.51% | 1.3B | |
-3.32% | 1.27B | |
-10.11% | 1.18B | |
+4.27% | 1.09B |